A carregar...
Are antiangiogenics a good ‘partner’ for immunotherapy in ovarian cancer?
Ovarian cancer (OC) is associated with poor survival because there are a limited number of effective therapies. Two processes key to OC progression, angiogenesis and immune evasion, act synergistically to promote tumor progression. Tumor-associated angiogenesis promotes immune evasion, and tumor-rel...
Na minha lista:
| Publicado no: | Angiogenesis |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer Netherlands
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7524856/ https://ncbi.nlm.nih.gov/pubmed/32691290 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10456-020-09734-w |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|